Big Pharma is under scrutiny in the blogosphere this week. Ed Silverman at Pharmalot reports on a study (published in PLoS Medicine) that finds drugmakers spend almost twice as much on marketing and promotion as they do on R&D; he also tells us who Big Pharma’s backing for president. Scott Hensley at the WSJ Health […]

Bloggers are summing up developments from 2007 and looking ahead to 2008: • Adrienne Germaine at RH Reality Check presents the Top Ten Wins for Women’s Health in 2007. • Matt Madia at Reg Watch summarizes Regulatory Policy News for the year. • Kevin Grandia at DeSmogBlog brings us the Top 5 YouTube Global Warming Videos of 2007. […]

With so much attention focused on the energy bill, it’s easy to forget some of the other important legislation coming out of Congress these days. Revere at Effect Measure reports on the NIH and CDC funding figures in the latest version of the appropriations bill, and Jake Young at Pure Pedantry goes into detail about […]

The Science Debate 2008 initiative (which we blogged about earlier) has prompted Janet Stemwedel at Adventures in Ethics and Science, Coturnix at A Blog Around the Clock, and Zuska at Thus Spake Zuska to suggest questions to be asked at a presidential science debate. I’m sure there are many other bloggers who’ve posed questions, but […]

Gristmill has been doing an excellent job of tracking the progress of energy legislation in Congress this week; highlights include: Nancy Pelosi’s ass-kicking, which allowed the House bill to return to something close to its former strength; A marathon session in the Senate’s Environment and Public Works Committee, featuring an endless stream of amendments; The […]

Nanotechnology is getting some attention these days. Revere at Effect Measure (which just celebrated its third blogiversary!) gauges the level of alarm about nanotechnology; at Science Progress, Michael Peroski looks at the current regulatory framework for nanotechnology, while Justin Masterman highlights the promise of nanotubes for cancer therapy; and Matt Madia at Reg Watch critiques […]

Bloggers have been looking at the numbers related to our health. WSJ’s The Numbers Guy sheds light on the calculations behind global HIV-infection figures, which the U.N.’s AIDS agency has revised sharply downwards, and Mead Over at Global Health Policy hopes that the revision will re-focus attention on the need for cost-effectiveness estimates in the […]

Bloggers are bringing us lots of drug news this week: Abel Pharmboy at Terra Sigillata explains why a decision by the Centers for Medicare and Medicaid Services is devastating news for lymphoma patients – and possibly for all cancer patients (here, too). Ed Silverman at Pharmalot considers the drop in new drug approvals by the […]

Recent research has been attracting attention, and bloggers help explain the findings – in some cases, more accurately than the traditional media outlets do: MarkH at denialism blog critiques the news coverage of the latest research on obesity, overweight, and mortality (Washington Post headline: “Being Overweight Isn’t All Bad, Study Says”) and reminds us that […]

A lot of public health-related legislation is making its way through Congress these days, and bloggers are taking note. Brian Beutler at Gristmill has been tracking America’s Climate Security Act, otherwise known as the Lieberman-Warner bill (background here). Emily Douglas and James Wagoner at RH Reality Check report on the good and bad things Congress […]